Thomas Plitz
Chief Executive Officer bei Chord Therapeutics SA
Vermögen: 1 804 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Thomas Plitz
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland.
2
| Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Plitz
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal | |
Commonfund Capital, Inc.
 Commonfund Capital, Inc. Investment ManagersFinance Commonfund Capital, Inc (Commonfund Capital) is a private equity and venture capital subsidiary of Commonfund Holding Co., Inc founded in 1988. The firm is headquartered in Wilton, Connecticut with additional offices in New York, California, London & China. | Investment Managers | Corporate Officer/Principal | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Malaria Consortium
 Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | Medical/Nursing Services | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| New Mexico State University | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree | |
| Xavier University of Louisiana | College/University | Undergraduate Degree | |
| University of Mumbai | College/University | Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Masters Business Admin Graduate Degree | |
| University of Bocconi | College/University | Masters Business Admin Masters Business Admin | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The private company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DMS IMAGING | Biotechnology | Chief Tech/Sci/R&D Officer | |
Farma Resa Imp SRL
 Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Part of Pierrel SpA, Farma Resa Imp SRL is an Italian company that specializes in the preparation of pharmaceutical tests. The private company is based in Cantu, Italy. Farma Resa Imp was acquired by Pierrel Research Italy SpA on September 30, 2010 for $2.14 million. | Pharmaceuticals: Major | Chief Executive Officer | |
APR Applied Pharma Research SA
 APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Biotechnology | Chief Executive Officer | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | ||
| Università degli Studi di Napoli Federico II | College/University | Graduate Degree | |
| Harvard Mit Health Sciences & Technology | College/University | Graduate Degree | |
| Columbia Law School | College/University | Graduate Degree | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor Private Equity Investor | |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Isenberg School of Management | College/University | Graduate Degree | |
| American School of Milan | College/University | Graduate Degree | |
| University of Massachusetts Amherst College of Natural Science | College/University | Undergraduate Degree | |
Aetna Partners GmbH
 Aetna Partners GmbH Investment ManagersFinance Aetna Partners GmbH provides investment services. It offers a small circle of private investors with a long term investment horizon and an entrepreneurial background the possibility to transact direct investments in real assets with growth potential. The company was founded by Hans C. Bodmer, Thomaz Burckhardt and Felix Werthemann and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
NovoCure GmbH
 NovoCure GmbH Pharmaceuticals: MajorHealth Technology Part of NovoCure Ltd., NovoCure GmbH is a German company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The company is based in Munich, Germany. The CEOs of the private company are Asaf Danziger, Wilhelmus C. M. Groenhuysen. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Founder | |
| Bristol-Myers Squibb Ilaçlari, Inc. | Chief Executive Officer | ||
| Bristol-Myers Squibb OOO | Chief Executive Officer | ||
| Organon Central East GmbH (Hanoi City Representative Office) | Corporate Officer/Principal | ||
| Dellmed Consulting | Founder | ||
NRG Therapeutics Ltd.
 NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Institute For Pharmacokinetic & Analytical Studies | Chief Executive Officer | ||
| New York Intellectual Property Law Education Foundation | Corporate Officer/Principal | ||
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 22 |
| Schweiz | 8 |
| Vereinigtes Königreich | 5 |
| Frankreich | 5 |
| Italien | 5 |
Sektoral
| Consumer Services | 19 |
| Health Technology | 17 |
| Finance | 6 |
| Health Services | 2 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 39 |
| Corporate Officer/Principal | 33 |
| Chief Executive Officer | 14 |
| Graduate Degree | 8 |
| Director of Finance/CFO | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Thomas Plitz
- Unternehmensverbindungen
